Ibuprofen can reduce glomerular filtration rate, particularly in patients with pre-existing chronic kidney disease, volume depletion, or heart failure
Clinicians treating PWS patients with GLP-1 medications typically require specialized knowledge of PWS pathophysiology and careful monitoring, as dosing and response patterns may differ from standard weight-loss populations
Discussion The results of the current meta-analysis, that included 60,080 patients with T2DM, 14,804 of whom without established CV disease, demonstrate that GLP-1RA reduce the risk of MACE by 14% in the overall diabetic population, with an apparently greater effect in patients with known CV disease as compared with those without established CV disease (16% vs 6% reduction, respectively)
It is promising
Semaglutide in obesity-related heart failure with preserved ejection fraction and type 2 diabetes
"I may have somebody with a BMI of 24, which is normal, but a body fat of 40